Evaluation of the Bioequivalence of a Combined Formulated Tablet

Clinical trial NCT01622790 · COMPLETED

Trial details

NCT number: NCT01622790
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2012-06-01
Primary completion: 2012-08-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.